원격 간질 시장 규모, 점유율, 동향 분석 보고서 : 환자별, 구성요소별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Tele-epilepsy Market Growth & Trends:

The global tele-epilepsy market size is expected to reach USD 1,161.5 million by 2030, registering a CAGR of 15.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. aided by the rising adult population suffering from epilepsy, and increased investments in the healthcare telemedicine ecosystem by governments and private players globally.

The COVID-19 pandemic had a positive impact on the tele-epilepsy industry. The outbreak severely impacted the healthcare system and the economy, which created a special barrier for individuals seeking medical care, including epilepsy care. In addition, telehealth initiatives have demonstrated a high level of patient and physician satisfaction and quality during COVID-19. It has been seen that providing complex epilepsy care, including to patients with severity in epilepsy, could be solved, and can produce results that are comparable to those of in-person consultations.

Governments worldwide are initiating programs to uplift the market for tele-epilepsy. For instance, several government entities are embracing telehealth by implementing new regulations and reimbursement standards. In March 2020, The Federal Communications Commission in the US developed initiatives to aid healthcare organizations in implementing telemedicine technology.

Tele-epilepsy Market Report Highlights:

• Based on patient, the adult segment led the market with the largest revenue share of 56.67% in 2024 and is anticipated to grow at a CAGR of 16.0% during the forecast period.
• Based on component, the hardware segment led the market with the largest revenue share of 40.8% in 2024, due to the extensive use of videoconferencing technology, audio equipment, microphones, and other medical accessories to support virtual visits.
• Based on end use, the healthcare consumer segment led the market with the largest revenue share of 42.4% in 2024, owing to the increasing empowerment of patients and their demand for more personalized and accessible healthcare solutions.
• North America tele-epilepsy market dominated with the largest revenue share of 37.2% in 2024, owing to the technologically advanced infrastructure, rising number of epilepsy cases, and growing per capita income.
• The Asia Pacific tele-epilepsy market is anticipated to register at the fastest CAGR during the forecast period, due to the increasing penetration of smartphones & smart wearable devices and the rising adoption of telehealth services.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Patient outlook
  • 2.2.2. Component outlook
  • 2.2.3. End use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Tele-epilepsy Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Tele-epilepsy: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Technology Timeline and Emerging Trends
• 3.5. Case Study Analysis

Chapter 4. Tele-epilepsy Market Segment Analysis, By Patient, 2018 - 2030 (USD Million)

• 4.1. Definition and Scope
• 4.2. Patient Market Share Analysis, 2024 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Tele-epilepsy Market, by Patient, 2018 to 2030
• 4.5. Pediatric
  • 4.5.1. Pediatric market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.6. Adult
  • 4.6.1. Adult market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Tele-epilepsy Market Segment Analysis, By Component, 2018 - 2030 (USD Million)

• 5.1. Definition and Scope
• 5.2. Component Market Share Analysis, 2024 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Tele-epilepsy Market, by Component, 2018 to 2030
• 5.5. Software
  • 5.5.1. Software market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.6. Hardware
  • 5.6.1. Hardware market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.7. Services
  • 5.7.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Tele-epilepsy Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

• 6.1. Definition and Scope
• 6.2. End Use Market Share Analysis, 2024 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Tele-epilepsy Market, by End Use, 2018 to 2030
• 6.5. Hospitals providers
  • 6.5.1. Hospitals providers market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Payers
  • 6.6.1. Payers market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.7. Healthcare consumers
  • 6.7.1. Healthcare consumers market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Tele-epilepsy Market Segment Analysis, By Region, By Patient, By Component, By End Use, 2018- 2030 (USD Million)

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Snapshot
• 7.4. Tele-epilepsy Market Share by Region, 2024 & 2030:
• 7.5. North America
  • 7.5.1. North America tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. U.S. tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Canada tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Mexico tele-epilepsy market, 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. UK tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Germany tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. France tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Italy tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Spain tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.6.7. Norway
    • 7.6.7.1. Norway tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Sweden tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.6.9. Denmark
    • 7.6.9.1. Denmark tele-epilepsy market, 2018 - 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Japan tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. China tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. India tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Australia tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. South Korea tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Thailand tele-epilepsy market, 2018 - 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Brazil tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Argentina tele-epilepsy market, 2018 - 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. South Africa tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Saudi Arabia tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. UAE tele-epilepsy market, 2018 - 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Kuwait tele-epilepsy market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Profiles
  • 8.3.1. Shimmer
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. Empatica
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. SOC Telemed
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Eagle Telemedicine
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Sevaro
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Tele Specialists
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Chiron Health
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. RTTC
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Science Soft USA Corporation
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Vidyo, Inc.
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives